Catalyst Wire Dossier Catalyst Wire Dossier

Melanotan II

Melanotan II · Hudson Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Melanotan II, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo [Phase 2]

See pricing